A clinical study was performed in 21 dogs to evaluate the efficacy of selamectin for the treatment of naturally acquired infection of sucking lice (Linognathus setosus [L.setosus]) in dogs. Each dog was randomly assigned to one of two treatment groups. One group was treated with selamectin applied topically at a mean dosage of 7.9 mg/kg. The other group was treated with permethrin applied topically at a mean dosage of 85.7 mg/kg. At day 42 posttreatment, all animals remaining in the study (10 treated with selamectin and six with permethrin) were clear of lice. In both groups, the reduction in lice counts from pretreatment values to day 42 was statistically significant at P≤0.0001. Selamectin applied topically appeared to be effective against L. setosus infection in dogs.
Introduction
Lice infections in dogs have been reported worldwide. The two most common lice species involved are Trichodectes canis (T. canis), the biting louse, and Linognathus setosus (L. setosus), the sucking louse. 1 Lice in dogs may cause various dermatological signs such as pruritus, erythema, crusting, scaling, and papules. 1,2 Heavy infections with L. setosus may also cause anemia, which can be potentially lethal. 1 Based on the appearance of the louse, the two species are easily differentiated. Linognathus setosus is approximately 5 mm long, bluish in color, and has a small, pointed head. 1 Trichodectes canis measures up to 3 mm, is yellowish in color, and has a relatively larger head that is rounded anteriorly. 1 Both species are flattened dorsoventrally. The clinical diagnosis of lice infection in a dog is easy, because both the lice and the eggs (so-called "nits") are visible to the naked eye. The eggs are usually attached to the affected dog's hair. The life cycle (i.e., from egg to adult) takes 2 to 3 weeks. 1 Lice are highly host-specific and are unable to survive away from the host for more than 2 days. 1 They are spread by direct contact or via contaminated brushes, combs, etc. 2 A wide range of insecticide compounds such as permethrin, phoxim, fipronil, and imidacloprid are effective against L. setosus and T. canis. a,b,c,d,1-4 These products may explain why lice infection in dogs is a rare diagnosis in the parts of the world where dogs are routinely treated against fleas. In other regions, such as northern Scandinavia, lice infection is considered to be common. However, it is difficult to accurately estimate the prevalence, because lice are easy to identify, and many dog owners treat their pets with an appropriate antiparasitic substance without ever consulting a veterinarian. In a Norwegian study carried out between January 1989 and May 1994, 543 dogs were found to be infected with ectoparasites, of which 344 (63%) were infected with lice. 5 An investigation conducted from 1996 to 1997 showed that L. setosus was the most common louse found on dogs in Sweden. 6 Samples from 180 dogs with lice were examined, and L. setosus was found in 175 cases. 6 The remaining five dogs had T. canis infection. 6 No case of a mixed infection was recorded. Linognathus setosus is also the most common louse found on dogs in Finland and the United Kingdom. 7, 8 Selamectin is an endectocide with a wide margin of safety for dogs of all breeds, and it is easy to administer since it is available in a topical spot-on formulation. 9 In dogs, selamectin is licensed to treat infections caused by Ctenocephalides spp., T. canis, Sarcoptes scabiei, Otodectes cynotis, and Toxocara canis. 9 It is also registered as a heartworm preventative. 9 The purpose of this study was to compare the effectiveness of a single topical administration of selamectin with a positive control (permethrin) in the treatment of natural infections of sucking lice in dogs.
Materials and Methods

Study Sites
Five veterinary practices, located in the middle and southern parts of Sweden, participated in the study, which took place from February 2001 to January 2002. Clinical examinations and treatments were carried out at those veterinary practices. The dogs were maintained at the homes of their owners for the duration of the study, which was 42 days. The study was approved by the Swedish National Board for Laboratory Animals and was conducted in accordance with good clinical veterinary practice.
Study Subjects
Twenty-one privately owned dogs infected with the sucking lice, L. setosus, were included in the study. To be eligible for the study, the dogs were at least 6 weeks old. Dogs with any concurrent diseases were not included in the study. Dogs that were regularly placed in daycare centers and dogs that had been treated with products effective against ectoparasites within the previous 60 days were also excluded.
All 21 dogs were clinically healthy, except for their lice infections. The presence of L. setosus was confirmed by microscopic examination at the Department of Parasitology, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Test and Control Materials
The test product was a commercial formulation, containing 12% selamectin in an isopropanol/glycol ether base. e The positive control product was a commercial formulation containing permethrin (744 mg/mL). a Both products are licensed for use in dogs.
Study Design
At enrollment in the study, a physical examination was performed, the extent of lice infection was confirmed, and an assessment of clinical abnormalities (e.g., pruritus, erythema, crusting, scaling, papules, and alopecia) was made. Lice were counted at hair partings at potential predilection sites [ Table 1 ]. A total of 17 sites were examined on each dog, with two spots counted at six of the sites; thus, the total number of counts per dog was 23. Only live lice were counted, and no distinction was made between nymphs and adult lice. Following identification of the louse species, the day of treatment for each dog was considered day 0.
Each dog was randomly allocated to one of the two treatment groups, using a previously prepared schedule. The list was produced by a random generator within SAS version 6. f The schedule was available only to the person administering the treatments. The veterinary examiners were blinded to the treatment used.
Body weights were recorded on day 0, and the dose or volume of the medication administered was determined by the manufacturer's recommendations. The hair was parted to allow direct application of both products to the skin. The selamectin treatment was administered on the midline at the base of the neck, according to the label instructions. Permethrin doses of 1 mL were administered on the midline at the base of the neck, and 2-mL doses were equally divided between the neck and the base of the tail, according to label instructions. The dogs were treated on only one occasion, regardless of which product was used. Ten minutes after each dog was treated on day 0, it was reexamined by the evaluating veterinarian for any adverse reactions. The dog was subsequently returned to its owner, who was instructed to observe the dog at home and to contact the veterinarian if any abnormal clinical signs were seen. Confirmation that no signs occurred during the first week after treatment was obtained when the dog was returned to the clinic on day 7.
The dogs were subsequently examined on days 7, 28, and 42. At each visit, a physical examination was performed, clinical signs were assessed, and lice counts were done. The principal parameter of efficacy for the two products was the determination and statistical analysis of the reduction in the lice counts during the 42 days following treatment.
Data Analysis
For each animal at each examination date, the total lice count was obtained by adding the lice counts from all sites. A natural logarithm transformation was applied to the total lice counts prior to analysis. The transformed variable was analyzed using a linear mixed model for repeated measurements. f A priori contrasts were used to assess the difference between the day 0 mean count and each of the posttreatment mean counts within each treatment group. Geometric means were calculated for each treatment at each day of the study by back-transformation of the least-squares means. f These geometric means were then used to estimate the percentage reduction in lice counts at days 7, 28, and 42, using the following formula:
Because a substantial withdrawal of animals occurred in the permethrin treatment group, the proportion of animals completing the study in the two treatment groups was analyzed using Fisher's exact test to examine the effect of treatment on completion of the study. All analyses were performed using a statistical analysis software program. f A P value <0.05, two-sided, was considered significant.
Results
Study Subjects
Twenty-one dogs were included in the study. Twenty different breeds, as well as a mixed-breed dog, were represented. Ages were known for 13 of the study animals and ranged from 4 months to 3 years. The mean age of the dogs was 2 years. The dogs ranged in weight from 4.4 to 60.2 kg. Table  2 gives details of the body weights and dosages administered for the 11 dogs treated with selamectin, and Table 3 gives the same data for the 10 dogs treated with permethrin. The dogs in the selamectin group ranged in weight from 7.4 to 37.0 kg. Dogs in the permethrin group ranged in weight from 4.4 to 60.2 kg. The mean weights of the two groups were 21.4 and 22.8 kg, respectively. The mean dose administered was 7.9 mg/kg (range 6.1 to 11.5 mg/kg) for the selamectin group and 85.7 mg/kg (range 24.7 to 169.1 mg/kg) for the permethrin group. Tables 4 and 5 provide summaries of the total lice counts for each dog from each treatment group on days 0, 7, 28, and 42, as well as the times dogs were withdrawn from the study for perceived lack of treatment efficacy. Four permethrin-treated dogs were withdrawn from the study (one on day 7, one on day 8, one on day 22, and one on day 28). Two dogs were withdrawn because of continued presence of lice, and the other two were withdrawn because of no improvement in skin condition. One of the 11 selamectin-treated dogs was withdrawn from the study at day 28. The owner wanted a different treatment for his dog when 31 lice were found at the examination. These five cases were regarded as treatment failures. One dog in the permethrin treatment group was not examined on day 42. The owner of this dog was contacted by phone on day 42, and because the dog exhibited no more clinical signs of lice infection, it was not regarded as a treatment failure. When analyzed by the Fisher's two-tailed test, the difference between the two groups in the numbers of dogs withdrawn from the study by day 42 was not significant (P=0.063).
Lice Counts
At day 7, no lice were found on the dogs treated with selamectin, but lice were found on three permethrin-treated dogs. At day 28, one of the 11 selamectin-treated dogs and one of the seven permethrin-treated dogs had lice. At day 42, all of the animals remaining in the study (10 selamectintreated dogs and six permethrin-treated dogs) were clear of lice [ Table 6 ].
In both treatment groups, the reduction in lice counts from the initial pretreatment values on day 0 to day 42 was highly statistically significant (P≤0.0001). To put these values into clinical context, however, it should be noted that the values are based on only a small number of dogs (10 selamectin-treated dogs and six permethrintreated dogs at day 42). The day 42 data resulted in overall clinical efficacy values of 91% (10/11 dogs) for selamectin and 60% (6/10 dogs) for permethrin. There were no significant differences (P=0.06357) in lice counts between the two treatment groups at any time point in the study.
Clinical Signs
The most common clinical sign at initial diagnosis was pruritus, followed by erythema, crusting, and scaling. At day 0 in the selamectin group, 10 of 11 dogs had pruritus; in the permethrin group, all dogs were pruritic. Pruritus was also the longest-lasting sign during the treatment period and remained at day 42 in three dogs in both treatment groups [ Table 7 ]. There were no statistically significant differences between the two groups. % Reduction=100 × [Geometric mean at day 0 -Geometric mean at day 7 (or 28 or 42) ÷ Geometric mean at day 0] 
Adverse Reactions
Each animal was examined before and 10 minutes after each treatment. The animals were given a physical examination on days 0, 7, 28, and 42. Owners were also instructed to return the animals to their veterinarians if any abnormal signs occurred between visits. No adverse reactions were seen at any of the examinations. One owner reported his dog as being very tired at home for a few hours after treatment with selamectin, but the dog was normal the following day.
Discussion
The results of the study reported here show that both selamectin and permethrin had a marked and statistically significant effect in reducing lice numbers by day 42. However, five animals were withdrawn from the study because of the continued presence of lice and persistent poor condition of the skin at the intermediate evaluation points. Thus, the significant reduction in lice burden from days 0 to 42 was based only on those 16 animals not withdrawn from the study. The reasons for treatment failure in five dogs were unknown. The four dogs that were treated with permethrin received doses ranging from 24.7 mg/kg to 106.3 mg/kg. Based on the recommended therapeutic dose (maximum of 744 mg for dogs weighing 5 kg; minimum of 1488 mg for dogs weighing >15 kg a ) for this product, treatment failure did not appear to be from a dose-related problem. Resistance of the lice to the permethrin might explain the results, but further investigation is needed. To the authors' knowledge, no other data to support such a theory have yet been published. Another explanation of treatment failure may be exposure to other dogs infected with lice; however, the owners of those dogs denied exposure to other dogs during the study period.
The distributions of clinical signs observed were similar in the two groups throughout the study, with pruritus being the most common sign both at the beginning and at the end of the study [ Table 7 ].
Conclusion
In the study reported here, a single treatment of selamectin applied topically was effective in the treatment of sucking lice infections in dogs. Because selamectin is safe and easy to administer, it may be a useful alternative in the treatment of not only T. canis but also L. setosus infections in dogs. 
